心血管病防治知识(下半月)
心血管病防治知識(下半月)
심혈관병방치지식(하반월)
XINXUEGUANBING FANGZHI ZHISHI
2014年
12期
72-74
,共3页
冠心病%慢性心力衰竭%室性心律失常
冠心病%慢性心力衰竭%室性心律失常
관심병%만성심력쇠갈%실성심률실상
Coronary heart disease%Chronic heart failure%Ventricular arrhythmias
目的:探讨冠心病慢性心力衰竭患者并发室性心律失常的有效治疗方法。方法选取我院在2012年1月至2014年1月收治的由冠心病导致的慢性心力衰竭合并室性心律失常患者60例,随机分为观察组和对照组,对照组给予常规治疗,观察组在常规治疗基础上加用胺碘酮口服治疗,并比较两组疗效。结果观察组患者治疗后的心率(HR)明显下降(P<0.05),QT间期(Q-Tc)以及左室射血分数(LVEF)明显增加(P<0.05),且与对照组治疗后比较差异显著(P<0.05)。结论对于冠心病慢性心力衰竭患者室性心律失常患者,在常规降血脂以及抗心衰治疗的基础上加用胺碘酮治疗可明显改善患者临床症状,提高疗效,改善患者预后。
目的:探討冠心病慢性心力衰竭患者併髮室性心律失常的有效治療方法。方法選取我院在2012年1月至2014年1月收治的由冠心病導緻的慢性心力衰竭閤併室性心律失常患者60例,隨機分為觀察組和對照組,對照組給予常規治療,觀察組在常規治療基礎上加用胺碘酮口服治療,併比較兩組療效。結果觀察組患者治療後的心率(HR)明顯下降(P<0.05),QT間期(Q-Tc)以及左室射血分數(LVEF)明顯增加(P<0.05),且與對照組治療後比較差異顯著(P<0.05)。結論對于冠心病慢性心力衰竭患者室性心律失常患者,在常規降血脂以及抗心衰治療的基礎上加用胺碘酮治療可明顯改善患者臨床癥狀,提高療效,改善患者預後。
목적:탐토관심병만성심력쇠갈환자병발실성심률실상적유효치료방법。방법선취아원재2012년1월지2014년1월수치적유관심병도치적만성심력쇠갈합병실성심률실상환자60례,수궤분위관찰조화대조조,대조조급여상규치료,관찰조재상규치료기출상가용알전동구복치료,병비교량조료효。결과관찰조환자치료후적심솔(HR)명현하강(P<0.05),QT간기(Q-Tc)이급좌실사혈분수(LVEF)명현증가(P<0.05),차여대조조치료후비교차이현저(P<0.05)。결론대우관심병만성심력쇠갈환자실성심률실상환자,재상규강혈지이급항심쇠치료적기출상가용알전동치료가명현개선환자림상증상,제고료효,개선환자예후。
Objective To investigate the effective treatment of patients with chronic heart failure and ventricular arrhythmias caused by coronary heart disease. Methods Sixty patients with chronic heart failure and ventricular arrhythmias caused by coronary heart disease who were admitted to our hospital from January 2012 to January 2014 were randomly divided into control group and observation group. The control group was given conventional treatment, while the observation group was given conventional treatment and oral amiodarone. Their clinical outcomes were compared. Results Compared with the control group, the observation group had a significantly decreased heart rate after treatment (P<0.05) and significantly increased QT interval and left ventricular ejection fraction (P<0.05). Conclusion For patients with chronic heart failure and ventricular arrhythmias caused by coronary heart disease, conventional antilipidemic and anti-heart failure therapy combined with amiodarone can significantly improve their clinical symptoms and clinical outcomes.